Eris Lifesciences Limited, a leading Indian branded formulations company, today announced a breakthrough step in expanding ...

Thank you, Sylvie. 2025 was a defining year for One Stop Systems, Inc. and reflects the successful execution of a multiyear strategy to reposition the company around high-performance, ruggedized ...

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2025 Earnings Call Transcript March 12, 2026 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.

PNNNew Delhi [India], March 16: India’s rapidly evolving business landscape is being shaped by a new generation of companies that are driving innovation across technology, digital marketing, ...

I tried a highly-customized Hyprland desktop that's meant for Linux pros - and didn't hate it ...

India, March 20 -- A major study published in Clinical Journal of the American Society of Nephrology examines how nonsteroidal anti-inflammatory drugs (NSAIDs) may affect long-term kidney health.

Get an overview of RLM Theory and its core concepts. Learn why long-context understanding, REPL environments, and sub-agents matter for modern AI applications.

In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...

Knight Therapeutics Inc., (TSX: GUD) ('Knight') a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Argentine affiliate, Laboratorio LKM S.A., and its Mexican affiliate, ...

Mumbai, examined an application filed by FMC India Private Limited seeking classification of two chemicals—Carbosulfan Technical and Clomazone Technical—under the Customs Tariff Act, 1975, following ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Getty Images Net worth is a clear way ...

Additionally, MONJUVI received accelerated approval in the United States in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma ...